
Caberdost 0.5 Tablet
Marketer
HAB Pharma
Salt Composition
Cabergoline (0.5mg)
Overview Caberdost 0.5 Tablet
Cabergoline 0.5mg tablets function as a dopamine agonist, primarily treating elevated prolactin levels. This medication also effectively suppresses lactation following stillbirth, abortion, or miscarriage. For optimal absorption, ingest Cabergoline 0.5mg tablets with food, maintaining a consistent daily administration time. Dosage and frequency are determined by your physician based on your specific condition and response to treatment. Always adhere to your doctor's prescribed regimen. Swallow the tablets whole with water. Continue using this medication for the duration specified by your doctor. Common side effects include nausea, headache, dizziness, and hypotension. Report any concerning or persistent side effects to your physician; management strategies may be available. To mitigate dizziness, avoid driving and rise gradually from a lying or seated position. Prior to commencing treatment, inform your physician of any history of postpartum hypertension or cardiac disease. Disclose current or planned pregnancies, breastfeeding, and all other medications being taken, as interactions may affect Cabergoline's efficacy or mechanism of action. Your doctor may monitor your blood pressure regularly during treatment.
Uses of Caberdost 0.5 Tablet
Managing hyperprolactinemia
Major Benefits of Caberdost 0.5 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Caberdost 0.5 Tablet whole; do not crush, chew, or divide it. Administer this medication with food.
Common Side effects of Caberdost 0.5 Tablet:
- Nausea
- Constipation
- Dizziness
- Fatigue
- Headache
- Vomiting
- Vertigo
- Abdominal pain
- Breast pain
- Sleepiness
- Valvulopathy and related disorders
- Dyspepsia
- Gastritis
- Weakness
- Depression
- Postural hypotension (low blood pressure)
- Hot flushes
How to use Caberdost 0.5 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Caberdost 0.5 Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.
How Caberdost 0.5 Tablet works:
Caberdost 0.5mg tablets reduce prolactin levels, a hormone crucial for lactation. This action suppresses milk production following stillbirth, abortion, or miscarriage.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Caberdost 0.5 Tablet with alcohol. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
Using Caberdost 0.5 Tablet during pregnancy poses a confirmed risk to the fetus. Its use should be avoided, except in critical circumstances where a physician deems the potential benefits outweigh the inherent dangers. Always seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
The use of Caberdost 0.5 Tablet while breastfeeding is likely unsafe. Limited evidence indicates potential transfer to breast milk, posing a risk to the infant. Caberdost 0.5 Tablet is typically avoided during breastfeeding due to its lactation-suppressing effect.
DrivingUNSAFE
Taking Caberdost 0.5 Tablet may cause drowsiness, blurred vision, and dizziness, reducing alertness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
The use of Caberdost 0.5 Tablet in individuals with kidney impairment is likely safe. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
LiverCAUTION
Patients with hepatic impairment should use Caberdost 0.5mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Caberdost 0.5 Tablet :
Omit any missed Caberdost 0.5 Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Caberdost 0.5 Tablet
| Label | Value |
|---|---|
| Chemical Type | Ergoline alkaloids |
| Developing Habits | No. |
| Treatment Category | Obstetrics and Gynecology |
| Behavioral Class | Elevated Prolactin from Dopamine Agonists |
